The chemical substance known as (Z)-4-((3-(1-carboxy-2-phenylethyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid, with the CAS number 306324-21-0, is characterized by its complex molecular structure, which includes a thiazolidinone core and a benzoic acid moiety. This compound features a thioxothiazolidin ring, which contributes to its potential biological activity, particularly in medicinal chemistry. The presence of a carboxylic acid group suggests that it may exhibit acidic properties, influencing its solubility and reactivity in various environments. The phenyl group attached to the ethyl chain may enhance its lipophilicity, potentially affecting its pharmacokinetics. Additionally, the (Z) configuration indicates a specific geometric arrangement around the double bond, which can significantly impact the compound's interactions with biological targets. Overall, this substance may be of interest in research related to drug development, particularly for its potential therapeutic applications. Further studies would be necessary to elucidate its specific properties and biological activities.

ZTB23(R) is the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.

(Z)-4-((3-(1-carboxy-2-phenylethyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid

306324-21-0: The chemical substance known as (Z)-4-((3-(1-carboxy-2-phenylethyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid, with the CAS number 306324-21-0, is characterized by its complex molecular structure, which includes a thiazolidinone core and a benzoic acid moiety. This compound features a thioxothiazolidin ring, which contributes to its potential biological activity, particularly in medicinal chemistry. The presence of a carboxylic acid group suggests that it may exhibit acidic properties, influencing its solubility and reactivity in various environments. The phenyl group attached to the ethyl chain may enhance its lipophilicity, potentially affecting its pharmacokinetics. Additionally, the (Z) configuration indicates a specific geometric arrangement around the double bond, which can significantly impact the compound's interactions with biological targets. Overall, this substance may be of interest in research related to drug development, particularly for its potential therapeutic applications. Further studies would be necessary to elucidate its specific properties and biological activities.

<p>ZTB23(R) is the first potent and selective inhibitor of Mycobacterium tuberculosis Zmp1.</p>

CAS 306324-21-0

(Z)-4-((3-(1-carboxy-2-phenylethyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid

ZTB23(R)

Ref: TM-T24397